| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |